help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2005-0681
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Germain-Lee, E. L.
Right arrow Articles by Levine, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Germain-Lee, E. L.
Right arrow Articles by Levine, M. A.
Endocrinology Vol. 146, No. 11 4697-4709
Copyright © 2005 by The Endocrine Society

A Mouse Model of Albright Hereditary Osteodystrophy Generated by Targeted Disruption of Exon 1 of the Gnas Gene

Emily L. Germain-Lee, William Schwindinger, Janet L. Crane, Rediet Zewdu, Larry S. Zweifel, Gary Wand, David L. Huso, Motoyasu Saji, Matthew D. Ringel and Michael A. Levine

Department of Pediatrics, Division of Pediatric Endocrinology (E.L.G.-L., J.L.C., R.Z.), The Ilyssa Center for Molecular and Cellular Endocrinology (E.L.G.-L., J.L.C., R.Z.), Departments of Neurosciences (L.S.Z.), Medicine and Psychiatry (G.W.), and Comparative Medicine (D.L.H.), The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287-2520; Weis Center for Research (W.S.), The Geisinger Clinic, Danville, Pennsylvania 17822; Divisions of Endocrinology, Oncology, and Human Cancer Genetics (M.S., M.D.R.), The Ohio State University College of Medicine and Arthur G. James Comprehensive Cancer Center, Columbus, Ohio 43210; and Department of Pediatric Endocrinology (M.A.L.), The Cleveland Clinic Foundation, Cleveland, Ohio 44195

Address all correspondence and requests for reprints to: Emily L. Germain-Lee, Division of Pediatric Endocrinology, Department of Pediatrics, The Johns Hopkins University School of Medicine, Park Building, Suite 211, 600 North Wolfe Street, Baltimore, Maryland 21287-2520. E-mail: egermain{at}jhmi.edu.

Albright hereditary osteodystrophy is caused by heterozygous inactivating mutations in GNAS, a gene that encodes not only the {alpha}-chain of Gs (G{alpha}s), but also NESP55 and XL{alpha}s through use of alternative first exons. Patients with GNAS mutations on maternally inherited alleles are resistant to multiple hormones such as PTH, TSH, LH/FSH, GHRH, and glucagon, whose receptors are coupled to Gs. This variant of Albright hereditary osteodystrophy is termed pseudohypoparathyroidism type 1a and is due to presumed tissue-specific paternal imprinting of G{alpha}s. Previous studies have shown that mice heterozygous for a targeted disruption of exon 2 of Gnas, the murine homolog of GNAS, showed unique phenotypes dependent on the parent of origin of the mutated allele. However, hormone resistance occurred only when the disrupted gene was maternally inherited. Because disruption of exon 2 is predicted to inactivate G{alpha}s as well as NESP55 and XL{alpha}s, we created transgenic mice with disruption of exon 1 to investigate the effects of isolated loss of G{alpha}s. Heterozygous mice that inherited the disruption maternally (–m/+) exhibited PTH and TSH resistance, whereas those with paternal inheritance (+/–p) had normal hormone responsiveness. Heterozygous mice were shorter and, when the disrupted allele was inherited maternally, weighed more than wild-type littermates. G{alpha}s protein and mRNA expression was consistent with paternal imprinting in the renal cortex and thyroid, but there was no imprinting in renal medulla, heart, or adipose. These findings confirm the tissue-specific paternal imprinting of GNAS and demonstrate that G{alpha}s deficiency alone is sufficient to account for the hormone resistance of pseudohypoparathyroidism type 1a.




This article has been cited by other articles:


Home page
EndocrinologyHome page
C. Aydin, N. Aytan, M. J. Mahon, H. A. W. Tawfeek, N. W. Kowall, A. Dedeoglu, and M. Bastepe
Extralarge XL{alpha}s (XXL{alpha}s), a Variant of Stimulatory G Protein {alpha}-Subunit (Gs{alpha}), Is a Distinct, Membrane-Anchored GNAS Product that Can Mimic Gs{alpha}
Endocrinology, August 1, 2009; 150(8): 3567 - 3575.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. I. Kaya, O. Ugur, S. S. Oner, M. Bastepe, and H. O. Onaran
Coupling of {beta}2-Adrenoceptors to XL{alpha}s and G{alpha}s: A New Insight into Ligand-Induced G Protein Activation
J. Pharmacol. Exp. Ther., April 1, 2009; 329(1): 350 - 359.
[Abstract] [Full Text] [PDF]


Home page
Mol Biol EvolHome page
S. Wadhawan, B. Dickins, and A. Nekrutenko
Wheels within Wheels: Clues to the Evolution of the Gnas and Gnal Loci
Mol. Biol. Evol., December 1, 2008; 25(12): 2745 - 2757.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
S. Krechowec and A. Plagge
Physiological Dysfunctions Associated with Mutations of the Imprinted Gnas Locus
Physiology, August 1, 2008; 23(4): 221 - 229.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Xie, M. Chen, O. Gavrilova, E. W. Lai, J. Liu, and L. S. Weinstein
Severe Obesity and Insulin Resistance due to Deletion of the Maternal Gs{alpha} Allele Is Reversed by Paternal Deletion of the Gs{alpha} Imprint Control Region
Endocrinology, May 1, 2008; 149(5): 2443 - 2450.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
V. Mariot, S. Maupetit-Mehouas, C. Sinding, M.-L. Kottler, and A. Linglart
A Maternal Epimutation of GNAS Leads to Albright Osteodystrophy and Parathyroid Hormone Resistance
J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 661 - 665.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
A. Plagge, G. Kelsey, and E. L Germain-Lee
Physiological functions of the imprinted Gnas locus and its protein variants G{alpha}s and XL{alpha}s in human and mouse
J. Endocrinol., February 1, 2008; 196(2): 193 - 214.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. C. Hsu, J. D. Groman, C. A. Merlo, K. Naughton, P. L. Zeitlin, E. L. Germain-Lee, M. P. Boyle, and G. R. Cutting
Patients with Mutations in Gs{alpha} Have Reduced Activation of a Downstream Target in Epithelial Tissues due to Haploinsufficiency
J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3941 - 3948.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. N. Long, S. McGuire, M. A. Levine, L. S. Weinstein, and E. L. Germain-Lee
Body Mass Index Differences in Pseudohypoparathyroidism Type 1a Versus Pseudopseudohypoparathyroidism May Implicate Paternal Imprinting of G{alpha}s in the Development of Human Obesity
J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 1073 - 1079.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Linglart, M. J. Mahon, M. A. Kerachian, D. M. Berlach, G. N. Hendy, H. Juppner, and M. Bastepe
Coding GNAS Mutations Leading to Hormone Resistance Impair in Vitro Agonist- and Cholera Toxin-Induced Adenosine Cyclic 3',5'-Monophosphate Formation Mediated by Human XL{alpha}s
Endocrinology, May 1, 2006; 147(5): 2253 - 2262.
[Abstract] [Full Text] [PDF]


Home page
IBMS BoneKEyHome page
M. Bastepe and H. Juppner
Pseudohypoparathyroidism, Gs{alpha}, and the GNAS Locus
IBMS BoneKEy, December 1, 2005; 2(12): 20 - 32.
[Full Text] [PDF]


Home page
IBMS BoneKEyHome page
S. L. Ferrari, E. Seeman, and G. J. Strewler
Clinical and Basic Research Papers - October 2005 Selections
IBMS BoneKEy, November 1, 2005; 2(11): 1 - 6.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society